1.Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
Jeong Ha MOK ; Bo Hyoung KANG ; Taehoon LEE ; Hyun Kyung LEE ; Hang Jea JANG ; Yu Ji CHO ; Doosoo JEON
Journal of Korean Medical Science 2017;32(4):636-641
Detailed information on additional drug resistance patterns of multidrug-resistant tuberculosis (MDR-TB) is essential to build an effective treatment regimen; however, such data are scarce in Korea. We retrospectively analyzed the results of phenotypic drug susceptibility testing (DST) of culture confirmed-TB patients from January 2010 to December 2014 in 7 university hospitals in Korea. MDR-TB was identified among 6.8% (n = 378) of 5,599 isolates. A total of 57.1% (n = 216) of the MDR-TB patients had never been treated for TB. Strains from MDR-TB patients showed additional resistance to pyrazinamide (PZA) (35.7%), any second-line injectable drug (19.3%), and any fluoroquinolone (26.2%). Extensively drug resistant TB comprised 12.4% (n = 47) of the MDR-TB patients. Of 378 MDR-TB patients, 50.3% (n = 190) were eligible for the shorter MDR-TB regimen, and 50.0% (n = 189) were fully susceptible to the 5 drugs comprising the standard conventional regimen (PZA, kanamycin, ofloxoacin, prothionamide, and cycloserine). In conclusion, the proportion of new patients and the levels of additional drug resistance were high in MDR-TB patients. Considering the high levels of drug resistance, the shorter MDR-TB treatment regimen may not be feasible; instead, an individually tailored regimen based on the results of molecular and phenotypic DST may be more appropriate in MDR-TB patients in Korea.
2.Acute Severe Symptomatic Hyponatremia Following Coronary Angiography.
Eul Sik JUNG ; Woong Chol KANG ; Young Rock JANG ; Sejoong KIM ; Ji Won YANG ; Kyounghoon LEE ; Taehoon AHN
Korean Circulation Journal 2011;41(9):552-554
Hyponatremia is a relatively common electrolyte disorder. Although severe acute hyponatremia following coronary angiography is rare, potentially lethal neurologic manifestations may result. We describe a patient with severe, symptomatic hyponatremia, an unusual complication of coronary angiography. Lack of familiarity with contrast media-related hyponatremia caused a delay in diagnosis and therapy in our case. The diagnosis of acute hyponatremia should be considered in any patient who develops behavioral or neurologic manifestations following coronary angiography. Prompt diagnosis and treatment is essential to avoid permanent neurologic damage or death.
Coronary Angiography
;
Humans
;
Hyponatremia
;
Neurologic Manifestations
;
Recognition (Psychology)
3.Acute Myocardial Infarction due to Polyarteritis Nodosa in a Young Female Patient.
Jin WI ; Hyun Hee CHOI ; Chan Joo LEE ; Taehoon KIM ; Sanghoon SHIN ; Young Guk KO ; Yangsoo JANG ; Yong Bum PARK ; Young Joo KWON
Korean Circulation Journal 2010;40(4):197-200
Coronary artery aneurysms are uncommon, are usually associated with atherosclerosis, and rarely involve all three major coronary arteries. The present report describes a rare case of a young female patient presenting with acute myocardial infarction (AMI). Coronary angiography revealed multiple severe aneurysmal and stenotic changes. Based on clinical feature and angiographic findings, it was strongly suspected that the patient had polyarteritis nodosa (PAN) complicated by AMI. The patient was treated with standard cardiac medications and immunosuppressive agents and has remained stable without further complications during a follow-up period of 6 months.
Aneurysm
;
Atherosclerosis
;
Coronary Aneurysm
;
Coronary Angiography
;
Coronary Vessels
;
Female
;
Follow-Up Studies
;
Humans
;
Immunosuppressive Agents
;
Myocardial Infarction
;
Polyarteritis Nodosa
;
Vasculitis
4.Trend of multidrug and fluoroquinolone resistance in Mycobacterium tuberculosis isolates from 2010 to 2014 in Korea: a multicenter study
Hyeonseok KIM ; Jeong Ha MOK ; Bohyoung KANG ; Taehoon LEE ; Hyun Kyung LEE ; Hang Jea JANG ; Yu Ji CHO ; Doosoo JEON
The Korean Journal of Internal Medicine 2019;34(2):344-352
BACKGROUND/AIMS:
This study was conducted to evaluate the recent prevalence and trend of anti-tuberculosis (TB) drug resistance with a focus on multidrug-resistance (MDR) and fluoroquinolone resistance in South Korea.
METHODS:
We retrospectively reviewed the drug susceptibility testing results of culture-confirmed Mycobacterium tuberculosis isolates collected from 2010 to 2014 at seven tertiary hospitals in South Korea.
RESULTS:
A total of 5,599 cases were included: 4,927 (88.0%) were new cases and 672 (12.0%) were previously treated cases. The MDR rate has significantly decreased from 6.0% in 2010 to 3.0% in 2014 among new cases, and from 28.6% in 2010 to 18.4% in 2014 among previously treated cases (p < 0.001 and p = 0.027, respectively). The resistance rate to any fluoroquinolone was 0.8% (43/5,221) in non-MDR-TB patients, as compared to 26.2% (99/378) in MDR-TB patients (p < 0.001). There was no significant change in the trend of fluoroquinolone resistance among both nonMDR-TB and MDR-TB patients. Among the 43 non-MDR-TB patients with fluoroquinolone resistance, 38 (88.4%) had fluoroquinolone mono-resistant isolates.
CONCLUSIONS
The prevalence of MDR-TB has significantly decreased from 2010 to 2014. The prevalence of fluoroquinolone resistance among non-MDR-TB patients was low, but the existence of fluoroquinolone mono-resistant TB may be a warning on the widespread use of fluoroquinolone in the community.
5.Characteristics and Effect of Rivaroxaban on Venous Thromboembolism in Korean Patients Compared to Western Population: A Subgroup Analysis from XALIA(-LEA) Study
Seung-Kee MIN ; Ji-Sun KIM ; Jang Yong KIM ; Ui Jun PARK ; Taehoon LEE ; Jin Mo KANG ; Sun Cheol PARK ; Won-Il CHOI ; Ki-Hyuk PARK ; Martin GEBEL
Vascular Specialist International 2022;38(4):33-
Purpose:
This study aimed to compare the characteristics of venous thromboembolic disease (VTE) in Korean to Caucasian population.
Materials and Methods:
XALIA-LEA and XALIA were phase IV non-interventional prospective studies with identical designs that investigated the effect of rivaroxaban versus standard anticoagulation for VTE. Koreans accounted for the largest proportion of the overall enrolled population of XALIA-LEA. However, in the XALIA study, most patients were Caucasian. Therefore, Korean data from XALIA-LEA and Caucasian data from XALIA were used in this study. This study compared the clinical characteristics and primary outcomes of the XALIA program, including major bleeding, recurrent VTE, and all-cause mortality.
Results:
The Korean population was older, was less obese, and had more active cancer at baseline than the Caucasian population. Provoked VTE was more common in the Korean population. Interestingly, Koreans showed less accompanying thrombophilia than Caucasians, and factor V Leiden mutations were not detected. Korean analyses comparing the effects of rivaroxaban and standard anticoagulation with primary outcomes showed a lower incidence of major bleeding, recurrent VTE, and all-cause mortality with rivaroxaban. Similar results were obtained in the propensity score matching analysis.
Conclusion
Characteristic differences were found between Korean and Caucasian VTE patients. Despite these ethnic differences, the effectiveness and safety of rivaroxaban therapy in these patients were consistent.
6.Microsurgical treatment of distal middle cerebral artery aneurysm: A single-center review
Taehoon JANG ; Sung-Tae KIM ; Jin LEE ; Won-Hee LEE ; Keun-Soo LEE ; Se-Young PYO ; Junghae KO ; Hangwoo LEE ; Yeong Gyun JEONG
Journal of Cerebrovascular and Endovascular Neurosurgery 2024;26(1):37-45
Objective:
To review the characteristics of distal middle cerebral artery (MCA) aneurysm treated by microsurgery, the detailed surgical options, and the clinical result.
Methods:
We retrospectively reviewed cerebral aneurysm in the M2 and M3 segments of the MCA surgically treated between January 2015 and December 2022. The demographic data, aneurysm-related findings, type of surgical approach, surgical technique, and clinical outcomes of the enrolled patients were analyzed.
Results:
Sixteen distal MCA aneurysms were treated with microneurosurgery (incidence, 1.0%; female, 12; mean age, 58.1 years; ruptured, three). Twelve aneurysms were in the M2 segment (insular segment), two aneurysms at the M2–M3 junction, and two aneurysms in the M3 segment (opercular segment). Twelve aneurysms were saccular (average size, 4.9 mm; multiplicity, 50%; average aneurysms, 3.0; partially thrombosed, 1; sidewall aneurysm, 2). Three aneurysms were fusiform, of which two were ruptured. Of the ruptured aneurysms, one was a ruptured dissecting aneurysm. The trans-sylvian and trans-sulcal approaches were used in fourteen and two patients, respectively. Neck clipping, wrap clipping, and surgical trapping were performed in twelve, one, and one patient, respectively. Proximal occlusion was performed in one patient. Bypass technique was required in two patients (neck clipping and proximal occlusion). The modified Rankin Score was 6 in the two patients with ruptured aneurysms. The remaining patients did not show further neurological deterioration after microneurosurgery.
Conclusions
Distal MCA aneurysms had a high incidence of being diagnosed with multiple other aneurysms and were relatively non-saccular.
7.Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent.
Byeong Keuk KIM ; Young Guk KO ; Seungjin OH ; Jung Sun KIM ; Woong Chol KANG ; Dong Woon JEON ; Joo Young YANG ; Donghoon CHOI ; Myeong Ki HONG ; Taehoon AHN ; Yangsoo JANG
Yonsei Medical Journal 2010;51(6):823-831
PURPOSE: Previous studies suggested that asymmetric stent expansion did not affect suppression of neointimal hyperplasia (NIH) after sirolimus-eluting stents (SES) implantation. The aim of this study was to evaluate the effects of stent eccentricity (SE) on NIH between SES versus paclitaxel-eluting stents (PES) using an intravascular ultrasound (IVUS) analysis from the randomized trial. MATERIALS AND METHODS: Serial IVUS data were obtained from Post-stent Optimal Expansion (POET) trial, allocated randomly to SES or PES. Three different SE (minimum stent diameter divided by maximum stent diameter) were evaluated; SE at the lesion site with maximal %NIH area (SE-NIH), SE at the minimal stent CSA [SE-minimal stent area (SE-MSA)], and averaged SE through the entire stent (SE-mean). We classified each drug-eluting stents (DES) into the concentric (> or = mean SE) and eccentric groups (< mean SE) based on the mean value of SE. RESULTS: Among 301 enrolled patients, 233 patients [SES (n = 108), PES (n = 125)] underwent a follow-up IVUS. There was no significant correlation between %NIH area and SE-NIH (r = - 0.083, p = 0.391) or SE-MSA (r = - 0.109, p = 0.259) of SES. However, SE-NIH of PES showed a weak but significant correlation with %NIH area (r = 0.269, p < 0.01). As to the associations between SE-mean and NIH volume index, SES revealed no significant correlation (r = - 0.001, p = 0.990), but PES showed a weak but significant correlation (r = 0.320, p < 0.01). However, there was no difference in the restenosis rate between the eccentric versus concentric groups of both DES. CONCLUSION: This study suggests that lower SE of both SES and PES, which means asymmetric stent expansion, may not be associated with increased NIH.
Aged
;
Angiography/methods
;
Coronary Restenosis/pathology/ultrasonography
;
*Drug-Eluting Stents
;
Female
;
Humans
;
Hyperplasia/*drug therapy/pathology
;
Immunosuppressive Agents/administration & dosage
;
Male
;
Middle Aged
;
Paclitaxel/*administration & dosage
;
Sirolimus/*administration & dosage
;
Tunica Intima
;
Ultrasonography, Interventional/methods
8.Bortezomib Treatment for Refractory Antibody-Mediated Rejection Superimposed with BK Virus-Associated Nephropathy during the Progression of Recurrent C3 Glomerulonephritis.
Wonseok DO ; Jong Hak LEE ; Kyung Joo KIM ; Man Hoon HAN ; Hee Yeon JUNG ; Ji Young CHOI ; Sun Hee PARK ; Yong Lim KIM ; Chan Duck KIM ; Jang Hee CHO ; Youngae YANG ; Minjung KIM ; Inryang HWANG ; Kyu Yeun KIM ; Taehoon YIM ; Yong Jin KIM
The Journal of the Korean Society for Transplantation 2018;32(3):57-62
A 38-year-old man, who underwent a second kidney transplantation (KT), was admitted because of antibody-mediated rejection (AMR) complicated by BK virus-associated nephropathy (BKVAN). He was placed on hemodialysis at the age of 24 years because of membranoproliferative glomerulonephritis. At the age of 28 years, he underwent a living donor KT from his father; however, 1 year after the transplantation, he developed a recurrence of the primary glomerular disease, resulting in graft failure 2 years after the first KT. Ten years later, he received a deceased-donor kidney with a B-cell-positive-cross-match. He received 600 mg of rituximab before the KT with three cycles of plasmapheresis and immunoglobulin (0.5 g/kg) therapy after KT. During the follow-up, the first and second allograft biopsies at 4 and 10 months after KT revealed AMR with a recurrence of primary glomerular disease that was reclassified as C3 glomerulonephritis (C3GN). He received a steroid pulse, rituximab, plasmapheresis, and immunoglobulin therapies. The third allograft biopsy demonstrated that the BKVAN was complicated with AMR and C3GN. As the azotemia did not improve after repeated conventional therapies for AMR, one cycle of bortezomib (1.3 mg/m²×4 doses) was administered. The allograft function stabilized, and BK viremia became undetectable after 6 months. The present case suggests that bortezomib therapy may be applicable to patients with refractory AMR, even in cases complicated with BKVAN.
Adult
;
Allografts
;
Azotemia
;
Biopsy
;
BK Virus
;
Bortezomib*
;
Fathers
;
Follow-Up Studies
;
Glomerulonephritis*
;
Glomerulonephritis, Membranoproliferative
;
Graft Rejection
;
Humans
;
Immunization, Passive
;
Immunoglobulins
;
Kidney
;
Kidney Transplantation
;
Living Donors
;
Plasmapheresis
;
Recurrence
;
Renal Dialysis
;
Rituximab
;
Transplants
;
Viremia
9.Patterns in renal diseases diagnosed by kidney biopsy: A single-center experience
Taehoon YIM ; Sang-Un KIM ; Sangmi PARK ; Jeong-Hoon LIM ; Hee-Yeon JUNG ; Jang-Hee CHO ; Chan-Duck KIM ; Yong-Lim KIM ; Man-Hoon HAN ; Yong-Jin KIM ; Ji-Young CHOI ; Sun-Hee PARK
Kidney Research and Clinical Practice 2020;39(1):60-69
Background:
The worldwide incidence of renal disease diagnosed by a kidney biopsy varies with age, race, sex, and region. Owing to a lack of studies and limited research resources for this disease in Korea, we investigated renal disease patterns by analyzing data from kidney biopsies performed over 13 years in a university-based teaching hospital in Korea.
Methods:
Among 2,053 kidney biopsies performed from 2001 to 2013 at Kyungpook National University Hospital, 1,924 were retrospectively analyzed for histopathologic, demographic, and clinical data as well as laboratory results.
Results:
Among the 1,924 studied kidney biopsies, 1,078 were males (56.0%) and the mean age was 37.7 ± 16.5 years. Asymptomatic urinary abnormalities were the most common clinical manifestation (62.5%). Immunoglobulin A nephropathy (IgAN) was the most common primary glomerular disease (37.4%), followed by minimal change disease (MCD), membranous nephropathy (MN), focal segmental glomerulonephritis and crescentic glomerulonephritis. Secondary glomerular diseases accounted for 10.3% of the total biopsies, with lupus nephritis being the most common (4.6%) followed by Henoch-Schönlein purpura nephritis and diabetic nephropathy. The most common cause of nephrotic syndrome was MCD (42.1%) followed by MN. Among patients seropositive for hepatitis B or C, IgAN (28.3% and 21.4%, respectively) was the most common cause.
Conclusion
IgAN and lupus nephritis were the most common primary and secondary glomerular diseases, respectively. Race, region, and practice patterns may affect renal disease patterns in different cohorts.